Yamamori, Yumeya http://orcid.org/0000-0001-5508-7965
Robinson, Oliver J. http://orcid.org/0000-0002-3100-1132
Funding for this research was provided by:
Medical Research Council (MR/R020817/1)
Wellcome Trust (222268/Z/20/Z)
Article History
Accepted: 22 February 2024
First Online: 8 March 2024
Declarations
:
: OJR’s MRC senior fellowship is partially in collaboration with Cambridge Cognition Ltd (who plan to provide in-kind contribution) and he is running an investigator-initiated trial with medication donated by Lundbeck (escitalopram and placebo, no financial contribution). He also holds an MRC-Proximity to discovery award with Roche (who provide in-kind contributions and have sponsored travel for ACP) regarding work on heart-rate variability and anxiety. He also has completed consultancy work for Peak, IESO digital health, Roche, and BlackThorn therapeutics. OJR sat on the committee of the British Association of Psychopharmacology until 2022. YY declares no conflicts of/competing interests.
: Not applicable.
: Not applicable.
: Not applicable.